Renaissance Technologies (RenTech)'s ENTX Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 473,442 shares of Entera Bio Ltd. (ENTX) worth $525,521, representing 0.00% of the portfolio. First purchased in 2020-Q4, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in ENTX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 365,441 shares. Largest reduction occurred in Q1 2023, reducing 129,200 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Entera Bio (ENTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Entera Bio (ENTX) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +365,441 | Add 338.37% | 473,442 | $1.11 |
| Q4 2025 | +19,601 | Add 22.17% | 108,001 | $1.94 |
| Q3 2025 | +24,100 | Add 37.48% | 88,400 | $1.92 |
| Q2 2025 | +1,000 | Add 1.58% | 64,300 | $1.90 |
| Q1 2025 | +1,500 | Add 2.43% | 63,300 | $1.70 |
| Q4 2024 | +600 | Add 0.98% | 61,800 | $2.12 |
| Q3 2024 | +3,600 | Add 6.25% | 61,200 | $1.90 |
| Q2 2024 | -17,300 | Reduce 23.10% | 57,600 | $1.84 |
| Q1 2024 | +17,500 | Add 30.49% | 74,900 | $1.67 |
| Q4 2023 | +34,000 | Add 145.30% | 57,400 | $0.59 |
| Q3 2023 | +7,300 | Add 45.34% | 23,400 | $0.73 |
| Q2 2023 | +5,700 | Add 54.81% | 16,100 | $0.00 |
| Q1 2023 | -129,200 | Reduce 92.55% | 10,400 | $0.01 |
| Q4 2022 | +118,300 | Add 555.40% | 139,600 | $0.00 |
| Q3 2022 | +21,300 | New Buy | 21,300 | $1.03 |
| Q1 2022 | -40,100 | Sold Out | 0 | $0.00 |
| Q4 2021 | +40,100 | New Buy | 40,100 | $2.82 |
| Q2 2021 | -120,407 | Sold Out | 0 | $0.00 |
| Q1 2021 | +48,221 | Add 66.80% | 120,407 | $3.81 |
| Q4 2020 | +72,186 | New Buy | 72,186 | $1.08 |
Renaissance Technologies (RenTech)'s Entera Bio Investment FAQs
Renaissance Technologies (RenTech) first purchased Entera Bio Ltd. (ENTX) in Q4 2020, acquiring 72,186 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Entera Bio Ltd. (ENTX) for 20 quarters since Q4 2020.
Renaissance Technologies (RenTech)'s largest addition to Entera Bio Ltd. (ENTX) was in Q1 2026, adding 473,442 shares worth $525,521.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 473,442 shares of Entera Bio Ltd. (ENTX), valued at approximately $525,521.
As of the Q1 2026 filing, Entera Bio Ltd. (ENTX) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Entera Bio Ltd. (ENTX) was 473,442 shares, as reported at the end of Q1 2026.